As gastrointestinal cancer outcomes were secondary or exploratory endpoints in the majority of included trials, these analyses are inherently vulnerable to type I error, outcome misclassification, and inadequate statistical power
We also provide targeted functional medicine treatments for immune system disorders, which can help mitigate these symptoms
Substantial published clinical research from Metabolic Pharmaceuticals' formal pharmaceutical development program (Phase 1, 2, and IIb trials)
Ozempic is the word on everyone's lips, and research reveals that the market for weight management supplements is worth over five billion USD, with analysts predicting a 14% uptick in the next ten years
doi: 10.1016/j.cmet.2013.08.005 245 SanyalACharlesEDNeuschwander-TetriBALoombaRHarrisonSAAbdelmalekMFet al
That mix clearly aims at working research labs, not casual buyers